Esperion(ESPR) - 2023 Q4 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET Company Participants Alexis Callahan - Head of Investor Relations Sheldon Koenig - President & Chief Executive Officer Benjamin Halladay - Chief Financial Officer Eric Warren - Chief Commercial Officer Conference Call Participants Serge Belanger - Needham Thomas Shrader - BTIG Jason Zemansky - Bank of America Na Sun - JPM Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to E ...